Glycosidases that convert natural glycosides to bioactive compounds. 1996

C K Sung, and G H Kang, and S S Yoon, and I S Lee, and D H Kim, and U Sankawa, and Y Ebizuka
College of Pharmacy, Chonnam National University, Kwangju, Korea.

UI MeSH Term Description Entries
D010946 Plants, Medicinal Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals. Herbs, Medicinal,Medicinal Herbs,Healing Plants,Medicinal Plants,Pharmaceutical Plants,Healing Plant,Herb, Medicinal,Medicinal Herb,Medicinal Plant,Pharmaceutical Plant,Plant, Healing,Plant, Medicinal,Plant, Pharmaceutical,Plants, Healing,Plants, Pharmaceutical
D006026 Glycoside Hydrolases Any member of the class of enzymes that catalyze the cleavage of the glycosidic linkage of glycosides and the addition of water to the resulting molecules. Endoglycosidase,Exoglycosidase,Glycohydrolase,Glycosidase,Glycosidases,Glycoside Hydrolase,Endoglycosidases,Exoglycosidases,Glycohydrolases,Hydrolase, Glycoside,Hydrolases, Glycoside
D006027 Glycosides Any compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. They are named specifically for the sugar contained, such as glucoside (glucose), pentoside (pentose), fructoside (fructose), etc. Upon hydrolysis, a sugar and nonsugar component (aglycone) are formed. (From Dorland, 28th ed; From Miall's Dictionary of Chemistry, 5th ed) Glycoside
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

C K Sung, and G H Kang, and S S Yoon, and I S Lee, and D H Kim, and U Sankawa, and Y Ebizuka
January 2014, BioMed research international,
C K Sung, and G H Kang, and S S Yoon, and I S Lee, and D H Kim, and U Sankawa, and Y Ebizuka
January 2010, Journal of pharmaceutical and biomedical analysis,
C K Sung, and G H Kang, and S S Yoon, and I S Lee, and D H Kim, and U Sankawa, and Y Ebizuka
January 2010, Topics in current chemistry,
C K Sung, and G H Kang, and S S Yoon, and I S Lee, and D H Kim, and U Sankawa, and Y Ebizuka
September 2018, Acta pharmaceutica Sinica. B,
C K Sung, and G H Kang, and S S Yoon, and I S Lee, and D H Kim, and U Sankawa, and Y Ebizuka
January 2009, Current pharmaceutical design,
C K Sung, and G H Kang, and S S Yoon, and I S Lee, and D H Kim, and U Sankawa, and Y Ebizuka
January 2022, Current drug discovery technologies,
C K Sung, and G H Kang, and S S Yoon, and I S Lee, and D H Kim, and U Sankawa, and Y Ebizuka
November 2019, Biomolecules,
C K Sung, and G H Kang, and S S Yoon, and I S Lee, and D H Kim, and U Sankawa, and Y Ebizuka
January 2000, Journal of medicinal food,
C K Sung, and G H Kang, and S S Yoon, and I S Lee, and D H Kim, and U Sankawa, and Y Ebizuka
January 2014, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
C K Sung, and G H Kang, and S S Yoon, and I S Lee, and D H Kim, and U Sankawa, and Y Ebizuka
June 1974, Comparative biochemistry and physiology. B, Comparative biochemistry,
Copied contents to your clipboard!